DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
45 hedge funds and large institutions have $6.44M invested in DMK Pharmaceuticals Corporation Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
45
Holding in Top 10
–
Calls
$510K
Puts
$26K
Top Buyers
| 1 | +$47K | |
| 2 | +$36.1K | |
| 3 | +$13K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.66K |
| 5 |
Jane Street
New York
|
+$9K |
Top Sellers
| 1 | -$99K | |
| 2 | -$27.3K | |
| 3 | -$27K | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$10K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$7.14K |